Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double Blinded, Placebo-Controlled Trial of Paliperidone Addition in SRI-Resistant Obsessive-Compulsive Disorder

NCT00632229 is registered in ClinicalTrials.gov with University of South Florida as lead sponsor.

NCT NCT00632229
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00632229 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double Blinded, Placebo-Controlled Trial of Paliperidone Addition in SRI-Resistant Obsessive-Compulsive Disorder
Lead sponsor
University of South Florida
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2007
Completion date
September 30, 2013
Enrollment
34 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

obsessive-compulsive disorder